Zhang, X., Li, S., & Liu, J. (2023). Remimazolam-remifentanil causes less postoperative nausea and vomiting than remimazolam-alfentanil during hysteroscopy: A single-centre randomized controlled trial. BMC Anesthesiology, 23(1), 1. https://doi.org/10.1186/s12871-023-02164-3
Chicago Style (17th ed.) CitationZhang, Xiaoqiang, Shuang Li, and Jing Liu. "Remimazolam-remifentanil Causes Less Postoperative Nausea and Vomiting than Remimazolam-alfentanil During Hysteroscopy: A Single-centre Randomized Controlled Trial." BMC Anesthesiology 23, no. 1 (2023): 1. https://doi.org/10.1186/s12871-023-02164-3.
MLA (9th ed.) CitationZhang, Xiaoqiang, et al. "Remimazolam-remifentanil Causes Less Postoperative Nausea and Vomiting than Remimazolam-alfentanil During Hysteroscopy: A Single-centre Randomized Controlled Trial." BMC Anesthesiology, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12871-023-02164-3.